<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Lerisetron</id>
	<title>Lerisetron - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Lerisetron"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Lerisetron&amp;action=history"/>
	<updated>2026-04-26T23:14:25Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Lerisetron&amp;diff=5368289&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Lerisetron&amp;diff=5368289&amp;oldid=prev"/>
		<updated>2024-03-06T03:43:49Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Lerisetron.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Lerisetron&amp;#039;&amp;#039;&amp;#039; is a [[pharmacological]] agent that is classified as a [[5-HT3 antagonist]]. It is primarily used in the prevention and treatment of [[chemotherapy]]-induced [[nausea]] and [[vomiting]] (CINV). &lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
[[Lerisetron]] works by blocking the action of [[serotonin]], a natural substance that may cause nausea and vomiting. It is a potent and selective [[5-HT3 receptor]] antagonist. The 5-HT3 receptors are located on the nerve terminals of the [[vagus nerve]] in the periphery, and centrally in the [[chemoreceptor trigger zone]] of the area postrema. &lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
[[Lerisetron]] is used to prevent nausea and vomiting caused by cancer chemotherapy. It is used in combination with other medications to prevent delayed nausea and vomiting that may occur a few days after receiving chemotherapy treatment. &lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of [[Lerisetron]] include headache, constipation, and fatigue. Serious side effects may include [[Serotonin Syndrome]], a potentially life-threatening condition that can occur with the use of 5-HT3 receptor antagonists.&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
[[Lerisetron]] was developed by [[Helsinn Healthcare]], a Swiss pharmaceutical company, in the late 1990s. It was approved for medical use in Europe in 1997, but is not currently approved for use in the United States.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[5-HT3 antagonist]]&lt;br /&gt;
* [[Chemotherapy-induced nausea and vomiting]]&lt;br /&gt;
* [[Serotonin Syndrome]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:5-HT3 antagonists]]&lt;br /&gt;
[[Category:Anti-emetics]]&lt;br /&gt;
{{Pharmacology-stub}}&lt;br /&gt;
{{5-HT3 antagonist-stub}}&lt;br /&gt;
{{Anti-emetic-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>